At ErythroSight (a spinout being incubated at ANU and Clear Vision Research), we are developing next-generation therapeutics for the treatment of retinal- and neuro-degenerations. Using Red Blood Cell Derived Extracellular Vesicles (RBC-EVs), we are developing a safe, inexpensive and personalised bl...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2023 (2 years)
Address:
131 GARRAN RD; ACTON, AUSTRALIAN CAPITAL TERRITORY 2601, AU
LOW
spending power
